Sodium Valproate in pharma franchise in Assam

Sodium Valproate in PCD pharma franchise in Itanagar

Sodium Valproate in top pharma company in Delhi

Sodium Valproate in pcd pharma supplier in Kanpur

Sodium Valproate in phama franchise company in India
Sodium Valproate in phama distributor in Indore

Home/Products /sodium-valproate-i-point-p-point-133mg-point--tablet

Valpotime CR 200

Composition : Sodium Valproate I.P. 133mg + Valproic Acid I.P. 58mg (C.R.)

Dosage Form : Tablet

Packaging Type : Strip Pack

Packaging : 10*10

Price : ₹156/-

Valpotime CR 200 is a controlled-release formulation containing a combination of Sodium Valproate (133mg) and Valproic Acid (58mg). This medication is primarily used for the treatment of epilepsy and bipolar disorder, offering long-lasting therapeutic effects with reduced frequency of dosing. The controlled-release mechanism ensures a steady and gradual release of the active ingredients, which helps in maintaining a consistent blood level of the drug, improving efficacy, and minimizing side effects.

Valpotime CR 200 works by stabilizing electrical activity in the brain, which is particularly helpful for managing seizures. It also helps in regulating mood swings associated with bipolar disorder, reducing the frequency and severity of manic episodes. The dual action of Sodium Valproate and Valproic Acid makes this medication effective in controlling both generalized and focal seizures and supporting long-term mental health stability.

This medication is typically prescribed for individuals suffering from epilepsy, seizure disorders, or bipolar disorder. The controlled-release formulation helps reduce the risk of side effects by maintaining steady drug levels, improving patient compliance and quality of life.

Read More

About the Product

Valpotime CR 200 is a controlled-release formulation containing a combination of Sodium Valproate (133mg) and Valproic Acid (58mg). This medication is primarily used for the treatment of epilepsy and bipolar disorder, offering long-lasting therapeutic effects with reduced frequency of dosing. The controlled-release mechanism ensures a steady and gradual release of the active ingredients, which helps in maintaining a consistent blood level of the drug, improving efficacy, and minimizing side effects.

Valpotime CR 200 works by stabilizing electrical activity in the brain, which is particularly helpful for managing seizures. It also helps in regulating mood swings associated with bipolar disorder, reducing the frequency and severity of manic episodes. The dual action of Sodium Valproate and Valproic Acid makes this medication effective in controlling both generalized and focal seizures and supporting long-term mental health stability.

This medication is typically prescribed for individuals suffering from epilepsy, seizure disorders, or bipolar disorder. The controlled-release formulation helps reduce the risk of side effects by maintaining steady drug levels, improving patient compliance and quality of life.

Common side effects include nausea, dizziness, weight gain, tremors, and drowsiness. Serious side effects may include liver toxicity, pancreatitis, or blood disorders. Contact a healthcare provider if unusual symptoms occur.

For the treatment of epilepsy, including generalized and focal seizures, and the management of bipolar disorder.

Consult a healthcare provider before use if pregnant, breastfeeding, or if you have liver disease. Regular blood tests may be required to monitor liver function.

Store in a cool, dry place, away from direct sunlight. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation